Raft ceramide in molecular medicine

Oncogene

Volumn 22, Issue 45 REV. ISS. 5, 2003, Pages 7070-7077

  Gulbins, Erich ^a   Kolesnick, Richard ^b  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Acid sphingomyelinase (ASM); Bacteria; Ceramide; Membrane platforms; Radiation; Rafts

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; CD4 ANTIGEN; CERAMIDE; CERAMIDE DERIVATIVE; DOXORUBICIN; FAS ANTIGEN; PACLITAXEL; SPHINGOLIPID; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE KINASE;

APOPTOSIS; ARTERY INTIMA PROLIFERATION; AUTOIMMUNE DISEASE; BACTERIAL INFECTION; BLOOD VESSEL INJURY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CARDIOVASCULAR DISEASE; CELL MEMBRANE; COLON CANCER; DEGENERATIVE DISEASE; DISEASE COURSE; HUMAN; HYDROGEN BOND; IONIZING RADIATION; NEUROBLASTOMA; NONHUMAN; OLIGOMERIZATION; PATHOGENESIS; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; STRESS; ULTRAVIOLET A RADIATION; VIRUS INFECTION;

ANIMALS; APOPTOSIS; AUTOIMMUNE DISEASES; CERAMIDES; DRUG THERAPY; HUMANS; MEMBRANE MICRODOMAINS; PREVENTIVE MEDICINE; SPHINGOMYELIN PHOSPHODIESTERASE;

BACTERIA (MICROORGANISMS);

EID: 0242574357     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207146     Document Type: Review

References (56)

1. Bejaoui K, Wu C, Scheffler MD, Haan G, Ashby P, Wu L, deJong P and Brown RH. (2001). Nat. Genet., 27, 261-262.
2. Bini L, Pacini S, Liberatori S, Valensin S, Pellegrini M, Raggiaschi R, Pallini V and Baldar CT. (2003). Biochem. J., 369, 301-309.
3. Brown DA and London E. (1998). J. Membr. Biol., 164, 103-114.
4. Charles R, Sandirasegarane L, Yun J, Bourbon N, Wilson R, Rothstein RP, Levison SW and Kester M. (2000). Circ. Res., 87, 282-288.
5. Chinnaiyan AM, O'Rourke K, Tewari M and Dixit VM. (1995). Cell, 81, 505-551.
6. Chung HS, Park SR, Choi EK, Park HJ, Griffin RJ, Song CW and Park H. (2003). Exp. Mol. Med., 35, 181-188.
7. Cifone MG, De Maria R, Roncaioli P, Rippo MR, Azuma M, Lanier LL, Santoni A and Testi R. (1994). J. Exp. Med., 180, 1547-1552.
8. Cremesti A, Lee H, Jendrossek V, McNabb T, Amoscato A, Grassmé H, Belka C, Fuks Z, Gulbins E and Kolesnick R. (2003). Fas activation induces surface ceramide elevation in discrete microdomains. (submitted for publication).
9. Cremesti A, Paris F, Grassmé H, Holler N, Tschopp J, Fuks Z, Gulbins E and Kolesnick R. (2001). J. Biol. Chem., 276, 23954-23961.
10. Dawkins JL, Hulme DJ, Brahmbhhatt SB, Auer-Grumg M and Nicholson GA. (2001). Nat. Genet., 27, 309-312.
11. Esen M, Schreiner B, Jendrossek V, Lang F, Fassbender K, Grassmé H and Gulbins E. (2001). Apoptosis, 6, 441-445.
12. Fanzo JC, Lynch MP, Phee H, Hyer M, Cremesti A, Grassmé H, Norris JS, Coggeshall KM, Rueda BR, Pernis AB, Kolesnick R and Gulbins E. (2003). Cancer Biol. Ther., 2, e55-e58.
13. Garcia-Barros M, Paris F, Cordon-Cardo C, Lyden D, Rafii S, Haimovitz-Friedman A, Fuks Z and Kolesnick R. (2003). Science, 300, 1155-1159.
14. Garcia-Ruiz C, Colell A, Mari M, Morales A, Calvo M, Enrich C and Fernandez-Checa JC. (2003). J. Clin. Investig., 111, 197-208.
15. Grassmé H, Gulbins E, Brenner B, Ferlinz K, Sandhoff K, Harzer K, Lang F and Meyer TF. (1997). Cell, 91, 605-615.
16. Grassmé H, Jekle A, Riehle A, Schwarz H, Berger J, Sandhoff K, Kolesnick R and Gulbins E. (2001). J. Biol. Chem., 276, 20589-20596.
17. Grassmé H, Jendrossek V, Bock J, Riehle A and Gulbins E. (2002). J. Immunol., 168, 298-307.
18. Grassmé H, Jendrossek V, Riehle A, von Kürthy G, Berger J, Schwarz H, Weller M, Kolesnick R and Gulbins E. (2003). Nat. Med., 9, 322-330.
19. Gulbins E, Bissonette R, Mahboubi A, Martin S, Nishioka W, Brunner T, Baier G, Baier-Bitterlich G, Byrd C, Lang F, Kolesnick R, Altman A and Green D. (1995). Immunity, 2, 341-351.
20. Hanada K, Palacpac NM, Magistrado PA, Kurokawa K, Rai G, Sakata D, Hara T, Horii T, Nishijima M and Mitamura T. (2002). J. Exp. Med., 195, 23-34.
21. Hauck CR, Grassmé H, Bock J, Jendrossek V, Ferlinz K, Meyer TF and Gulbins E. (2000). FEBS Lett., 478, 260-266.
22. Holopainen JM, Subramanian M and Kinnunen PK. (1998). Biochemistry, 37, 17562-17570.
23. Huang HW, Goldberg EM and Zidovetzki R. (1999). Biophys. J., 77, 1489-1497.
24. Hueber AO, Bernard AM, Herincs Z, Couzinet A and He HT. (2002). EMBO Rep., 3, 190-196.
25. Jan JT, Chatterjee S and Griffin DE. (2000). J. Virol., 74, 6425-6432.
26. Kirschnek S, Paris F, Weller M, Ferlinz K, Riehle A, Fuks Z, Kolesnick R and Gulbins E. (2000). J. Biol. Chem., 275, 27316-27323.
27. Kolesnick RN and Paley AE. (1987). J. Biol. Chem., 262, 9204-9210.
28. Lavie Y, Cao H, Bursten SL, Giuliano AE and Cabot MC. (1996). J. Biol Chem., 271, 19530-19536.
29. Liu YY, Han TY, Giuliano AE and Cabot MC. (2001). FASEB J., 15, 785-791.
30. Lucci A, Cho WI, Han TY, Giuliano AE, Morton DL and Cabot MC. (1998). Anticancer Res., 18, 475-480.
31. Maurer BJ, Melton L, Billups C, Cabot MC and Reynolds CP. (2000). J. Natl. Cancer Inst., 92, 1897-1909.
32. Michael JM, Lavin MF and Watters DJ. (1997). Cancer Res., 57, 3600-3605.
33. Morita Y, Perez GI, Paris F, Miranda SR, Ehleiter D, Haimovitz-Friedman A, Fuks Z, Xie Z, Reed JC, Schuchman EH, Kolesnick RN and Tilly JL. (2000). Nat. Med., 6, 1109-1114.
34. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME and Dixit VM. (1996). Cell, 85, 817-827.
35. Nurminen TA, Holopainen JM, Zhao H and Kinnunen PK. (2002). J. Am. Chem. Soc., 124, 12129-12134.
36. Okazaki T, Bell RM and Hannun YA. (1989). J. Biol. Chem., 264, 19076-19080.
37. Paris F, Fuks Z, Kang A, Capodieci P, Juan G, Ehleiter D, Haimovitz-Friedman A, Cordon-Cardo C and Kolesnick R. (2001). Science, 293, 293-297.
38. Paris F, Grassmé H, Cremesti A, Zager J, Fong Y, Haimovitz-Friedman A, Fuks Z, Gulbins E and Kolesnick R. (2000). J. Biol. Chem., 276, 8297-8305.
39. Paris F, Perez GI, Fuks Z, Haimovitz-Friedman A, Nguyen H, Bose M, Ilagan A, Hunt PA, Morgan WF, Tilly JL and Kolesnick R. (2002). Nat. Med., 8, 1329.
40. Pena LA, Fuks Z and Kolesnick RN. (2000). Cancer Res., 60, 321-327.
41. Rafii S and Lyden D. (2003). Nat. Med., 9, 702-712.
42. Santana P, Pena LA, Haimovitz-Friedman A, Martin S, Green D, McLoughlin M, Cordon-Cardo C, Schuchman EH, Fuks Z and Kolesnick R. (1996). Cell, 86, 189-199.
43. Schuchman EH, Suchi M, Takahashi T, Sandhoff K and Desnick RJ. (1991). J. Biol. Chem., 266, 8531-8539.
44. Schütze S, Potthoff K, Machleidt T, Berkovic D, Wiegmann K and Krönke M. (1992). Cell, 71, 765-776.
45. Schwartz GK, Ward D, Saltz L, Casper ES, Spiess T, Mullen E, Woodworth J, Venuti R, Zervos P, Storniolo AM and Kelsen DP. (1997). Clin. Cancer Res., 3, 537-543.
46. Seino KI, Kayagaki N, Takeda K, Fukao K, Okumura K and Yagita H. (1997). Gastroenterology, 113, 1315-1322.
47. Selzner M, Bielawska A, Morse MA, Rudiger HA, Sindram D, Hannun YA and Clavien PA. (2001). Cancer Res., 61, 1233-1240.
48. Simons K and Ikonen E. (1997). Nature, 387, 569-572.
49. Singer SJ and Nicolson GL. (1972). Science, 175, 720-731.
50. Spinedi A, Bartolomeo SD and Piacentini M. (1998). Cell Death Differ., 5, 785-791.
51. ten Grotenhuis E, Demel RA, Ponec M, Boer DR, van Miltenburg JC and Bouwstra JA. (1996). Biophys. J., 71, 1389-1399.
52. Veiga MP, Arrondon JL, Goni FM and Alonso A. (1999). Biophys. J., 16, 342-350.
53. Wang H, Maurer BJ, Reynolds CP and Cabot MC. (2001). Cancer Res., 61, 5102-5105.
54. Wang ZQ, Dudhane A, Orlikowski T, Clarke K, Li X, Darzynkiewicz Z and Hoffmann MK. (1994). Eur. J. Immunol., 24, 1549-1552.
55. Yu ZF, Nikolova-Karakashian M, Zhou D, Cheng G, Schuchman EH and Mattson MP. (2000). J. Mol. Neurosci., 15, 85-97.
56. Zhang Y, Mattjus P, Schmid PC, Dong Z, Zhong S, Ma WY, Brown RE, Bode AM, Schmid HH and Dong Z. (2001). J. Biol. Chem., 276, 11775-11782.